The National Human Rights Commission took cognisance of the violence and issued notices to chief secretary and the director general of police, calling for detailed reports in two weeks.
Infotech will see a mixed appraisal season.
New Delhi is approaching Gota with an open mind, observes N Sathiya Moorthy.
Looking back at Rajinikanth's film journey.
While the two high-profile exits in pharmaceutical and telecom have raised concerns over regulatory hassles in the country, Japanese investors are still keen to tap into India's consumer growth story and many more merger and acquisition deals are in the offing in this space.
Mitra Biotech's personalised cancer therapy could be a game changer in the field of cancer medicine.
The director talks about his new hit, Madras.
Power2SME, a one-stop shop for sourcing and buying raw materials for SMEs, is the only B2B firm in this space.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances